BEIJING, Sept. 02, 2015 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has showcased its wearable sleep respiratory product and solution at two premier sleep respiratory conferences, including: 1) the 4th National Sleep Respiratory Conference (the “NSRC”) which took place in Shanghai; and 2) the 2nd Sleep Medicine Annual Conference (the “SMAC”) which took place in Qingdao City, Shandong Province.
Sponsored by the Chinese Medical Association and Chinese Medical Doctor Association, respectively, the NSRC and SMAC are among the most influential gatherings of researchers and practitioners in the field of sleep and respiratory care. This year, hundreds of attendees drawn from leading hospitals, businesses, government, and academia attended the two conferences. Philips Respironics, ResMed, and Fisher & Paykel Healthcare are among global sleep and respiratory market leaders who also participated in the two conferences.
Sleep and respiratory experts who attended the two conferences gave positive reviews to the Company’s wearable sleep respiratory product and solution for its improved efficiency and comparable accuracy versus alternative OSAS diagnosis device such as PSG. Additionally, the importance of interdisciplinary research and interdisciplinary clinic practice in advancing sleep and respiratory care was discussed at both conferences with experts and industry practitioners calling for concerted effort across different organizations as well as different departments (e.g., cardiology, neurology, endocrinology, sleep, and respiratory care, etc.) within the same hospital.
Ms. Reyna Dong, Marketing Director of Dehaier's Sleep Respiratory Products Division stated, "The NSRC and SMAC conferences provided great venue for us to raise the awareness of our wearable sleep respiratory product and solution among respiratory care and sleep professionals whose academic authority and influence can help facilitate our market development. While we are encouraged by the market reception, we plan to further our sales and marketing efforts in coming quarters, through participation in similar conferences as well as cooperation with distributors, sales agents, leading hospitals, physical examination centers and research institutions.”
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, marketing and sale of medical products, including medical devices and wearable sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and eleven software copyrights. More information may be found at http://www.dehaier.com.cn.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact: Dehaier Medical Systems Limited Janice Wang +86 10-5166-0080 email@example.com Weitian Investor Relations Tina Xiao +1-917-609-0333 Tina.firstname.lastname@example.org
Source:Dehaier Medical Systems Limited